Pyridinaminosulfonyl substituted benzamides as inhibitors of cytochrome P450 3A4 (CYP3A4)

Details for Australian Patent Application No. 2006293605 (hide)

Owner Pfizer Products Inc.

Inventors Nambu, Mitchell David; Sakata, Sylvie Kim; Patterson, Brian Douglas; Patel, Leena Bharat Kumar; Tatlock, John Howard

Agent Allens Arthur Robinson

Pub. Number AU-B-2006293605

PCT Pub. Number WO2007/034312

Priority 60/821,664 07.08.06 US; 60/720,151 23.09.05 US; 60/723,115 03.10.05 US; 60/725,469 11.10.05 US; 60/762,256 25.01.06 US

Filing date 11 September 2006

Wipo publication date 29 March 2007

Acceptance publication date 19 May 2011

International Classifications

C07D 213/76 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61P 39/00 (2006.01) General protective or antinoxious agents

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/034312 Priority application(s): WO2007/034312

19 May 2011 Application Accepted

  Published as AU-B-2006293605

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006293613-PDGF amphiphilic polymer complex

2006293599-Water tube boiler